These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20404127)

  • 1. Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
    Grinwis ME; Sibley CD; Parkins MD; Eshaghurshan CS; Rabin HR; Surette MG
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2823-9. PubMed ID: 20404127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility and molecular mechanisms of macrolide resistance in streptococci isolated from adult cystic fibrosis patients.
    Thornton CS; Grinwis ME; Sibley CD; Parkins MD; Rabin HR; Surette MG
    J Med Microbiol; 2015 Nov; 64(11):1375-1386. PubMed ID: 26408040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of six macrolides, clindamycin and tetracycline on Streptococcus pneumoniae with different penicillin susceptibilities.
    Poulsen RL; Knudsen JD; Petersen MB; Fuursted K; Espersen F; Frimodt-Møller N
    APMIS; 1996 Mar; 104(3):227-33. PubMed ID: 8611198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.
    Giovanetti E; Montanari MP; Mingoia M; Varaldo PE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1935-40. PubMed ID: 10428916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Macrolide resistance phenotypes and genotypes in group G streptococci].
    Açikgöz ZC; Göçer S; Almayanlar E
    Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.
    Hasenbein ME; Warner JE; Lambert KG; Cole SE; Onderdonk AB; McAdam AJ
    J Clin Microbiol; 2004 Apr; 42(4):1559-63. PubMed ID: 15071004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.
    Alós JI; Aracil B; Oteo J; Torres C; Gómez-Garcés JL
    J Antimicrob Chemother; 2000 May; 45(5):605-9. PubMed ID: 10797081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal.
    Adhikari RP; Shrestha S; Barakoti A; Amatya R
    BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Macrolide-resistant Streptococcus pneumoniae in the pediatric population in Beijing].
    Yang H; Shen XZ; Wang YH; Yuan L; Yu SJ; Yang YH
    Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):936-9. PubMed ID: 15733368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
    Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
    Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1867-70. PubMed ID: 9303375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
    Tamayo J; Pérez-Trallero E; Gómez-Garcés JL; Alós JI;
    J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.
    Nagai K; Davies TA; Ednie LM; Bryskier A; Palavecino E; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3242-5. PubMed ID: 11600391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011.
    Kasai A; Ogihara S; Yamada K; Tanimichi Y; Nishiyama H; Saito R
    J Med Microbiol; 2015 Jul; 64(7):708-713. PubMed ID: 25934551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
    Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Streptococcus milleri group--an unrecognized cause of disease in cystic fibrosis: a case series and literature review.
    Parkins MD; Sibley CD; Surette MG; Rabin HR
    Pediatr Pulmonol; 2008 May; 43(5):490-7. PubMed ID: 18383109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.